Portola Pharmaceuticals

Portola Pharmaceuticals’ Drug to Prevent Blood Clots Wins FDA Nod
Xconomy
Sat, 06/24/17 - 09:20 am
Portola Pharmaceuticals
blood clots
FDA
Bevyxxa
betrixaban
Two Red Hot Biotechs With Big Near-term Catalysts Ahead
Motley Fool
Mon, 05/29/17 - 12:09 pm
biotech
Portola Pharmaceuticals
betrixiban
andexanet alfa
Neos
Adzenys XR-ODT
ADHD
Cotempla XR-OTD
Concerta
3 Top Biotech Stocks For May
Motley Fool
Thu, 05/11/17 - 06:27 pm
biotech
Galapagos
INSYS Therapeutics
Portola Pharmaceuticals
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
2 Top Stocks in Biotech
Motley Fool
Mon, 01/9/17 - 09:47 am
biotech
Portola Pharmaceuticals
Regeneron
After Losing Medivation, Who Is Gilead Going After Next?
Forbes
Mon, 09/19/16 - 03:39 pm
Medivation
Gilead Sciences
M&A
Puma Biotechnology
Kite Pharma
Incyte
Portola Pharmaceuticals
When Can Portola's Drug Be Approved, And How Much Does It Matter?
Seeking Alpha
Wed, 08/24/16 - 10:51 am
Portola Pharmaceuticals
andexanet alfa
FDA
Portola Approval And Headache Data From Lilly
Seeking Alpha
Sat, 08/13/16 - 02:51 pm
Portola Pharmaceuticals
Eli Lilly
andexanet alfa
galcanezumab
5 Small-Cap Biotechs With Big Potential
TheStreet.com
Mon, 08/1/16 - 09:26 am
biotech
Portola Pharmaceuticals
Progenics
Redhill Biopharma
Dynavax
Amicus Therapeutics
These 3 Biotechs Have Automatic Demand
Motley Fool
Mon, 07/25/16 - 09:55 am
biotech
Acadia
Portola Pharmaceuticals
Ophthotech
Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
Forbes
Mon, 07/25/16 - 09:51 am
biotech
M&A
Pfizer
Teva Pharmaceutical
Allergan
Shire
Portola Pharmaceuticals
Sanofi
Medivation
Regeneron
Biogen
The Promise Of Portola Pharmaceuticals
Seeking Alpha
Mon, 05/30/16 - 10:10 am
Portola Pharmaceuticals
3 Biotech Takeover Targets That Could Get Bought Soon
Motley Fool
Wed, 04/13/16 - 10:32 pm
biotech
M&A
Kite Pharma
Portola Pharmaceuticals
Medivation
Biotech's Top 5 Stock Winners, And Losers, In Q1 2016
Forbes
Thu, 03/31/16 - 09:49 pm
biotech
PTC Therapeutics
Celldex Therapeutics
Biocryst
Puma Biotechnology
Portola Pharmaceuticals
MedicNova
BioTie Therapies
Editas Medicine
AveXis
Inovio
Portola's Lesson For 'Innovative' Clinical Trial Designers
Forbes
Thu, 03/31/16 - 10:33 am
Portola Pharmaceuticals
clinical trials
betrixaban
8 Biotech Stocks That Have a ‘Greater Probability’ of Being Acquired
Barron's
Tue, 03/29/16 - 12:24 pm
biotech
M&A
Ardelyx
Ophthotech
Medivation
Puma Biotechnology
Ultragenyx
Portola Pharmaceuticals
Versartis
Relypsa
Portola stock tumbled after disappointing phase 3 trial data
Marketwatch
Thu, 03/24/16 - 09:58 am
Portola Pharmaceuticals
clinical trials
venous thromboembolism
3 Biotech Stocks to Buy in March
Motley Fool
Sat, 03/19/16 - 01:55 pm
biotech
Portola Pharmaceuticals
Regeneron
Ionis Pharmaceuticals
Portola Pharmaceuticals posts 4Q loss
Yahoo/AP
Fri, 02/26/16 - 03:19 pm
Portola Pharmaceuticals
earnings
5 Biotech Predictions for 2016
Motley Fool
Sat, 01/9/16 - 10:50 am
biotech
GW Pharma
Medical Marijuana
Big Pharma
Alzheimer's disease
CAR-T
Portola Pharmaceuticals
Eli Lilly
Biogen
Axovant Sciences

Pages